Financhill
Back

Denali Therapeutics Stock Predictions

Denali Therapeutics Stock Forecast

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 21% based on the past 6 years of stock performance.
  • Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Denali Therapeutics Stock Undervalued?
    The current Denali Therapeutics [DNLI] share price is $28.00. The Score for DNLI is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Denali Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 21% based on the past 6 years of stock performance.

Denali Therapeutics Stock Rating

Buy
58
Denali Therapeutics (DNLI) is a Buy

Is Denali Therapeutics overpriced?

  • Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Denali Therapeutics Stock Price History

Is DNLI stock going to rise?

  • The current trend is moderately bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com

52-Week Data

52-Week High:
32.13
52-Week Low:
14.56

Prediction Charts

Market Cap:
4.01B
Price in USD:
28.00
Volume:
882.97K
Beta:
1.56

Technical Analysis

SMA50:
26.19
SMA100:
23.98
SMA200:
21.28
52-Wk Change:
30.35%

Stock Predictions

  • Is Denali Therapeutics stock public?
    Yes, Denali Therapeutics is a publicly traded company.
  • What is the Denali Therapeutics stock quote today?
    The Denali Therapeutics stock price is 28.00 USD today.
  • How to buy Denali Therapeutics stock online?
    You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-24 30.24 30.32 30.51 29.58
Sep-25 30.52 29.00 30.54 28.93
Sep-26 29.37 29.27 29.64 28.83
Sep-27 29.50 29.43 29.80 29.22
Sep-30 29.12 29.13 29.32 28.50
Oct-1 29.18 28.69 29.67 28.46
Oct-2 28.37 29.03 29.07 28.02
Oct-3 28.69 28.22 28.88 28.12
Oct-4 28.51 28.63 28.97 28.38
Oct-7 27.89 26.60 27.89 26.22
Oct-8 26.68 26.72 27.47 26.30
Oct-9 26.82 26.52 27.03 26.35
Oct-10 26.00 25.74 26.02 25.28
Oct-11 25.59 28.00 28.07 25.59

Denali Therapeutics Earnings

Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Denali Therapeutics Forecast Revenue Growth

Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.06 per share.

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.